Compliance

Medical Consumables Registration in Latin America: Brazil ANVISA RDC 751/2022 vs Mexico COFEPRIS

For international medical device distributors, entering Latin America offers massive volume potential through Brazil's public SUS (Sistema Único de Saúde) hospital system and Mexico's IMSS (Instituto Mexicano del Seguro Social). However, regulatory harmonization differs sharply between Brazil's newly enacted RDC 751/2022 and Mexico's COFEPRIS sanitary registration pathways. Sourcing directly from Manshav Impex provides pre-formatted Spanish and Portuguese technical files and ISO 13485 QMS validation. Here is the strategic comparison.

Medical Consumables Registration in Latin America: Brazil ANVISA RDC 751/2022 vs Mexico COFEPRIS
Key Summary & AI Takeaways

Latin America's two healthcare powerhouses—Brazil and Mexico—represent over 65% of the region's $18B medical device market. Here is the technical dossier guide comparing Brazil's modernized ANVISA RDC 751/2022 framework with Mexico's COFEPRIS equivalence decree.

LatAm Regulatory Overview

Brazil's ANVISA RDC 751/2022 harmonizes risk classifications with the EU MDR, replacing legacy notifications with structured technical dossiers and mandatory INMETRO electrical safety or BGMP audit requirements for Class III/IV devices. Mexico's COFEPRIS offers an expedited Equivalence Pathway for manufacturers holding US FDA 510(k) or Health Canada licenses. Manshav Impex supports Latin American importers with comprehensive technical dossiers in English, Spanish, and Portuguese.

Regulatory Comparison: ANVISA (Brazil) vs. COFEPRIS (Mexico)

Understanding the procedural differences between Brazil's Agência Nacional de Vigilância Sanitária (ANVISA) and Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) is critical for structuring regional distribution contracts.

Regulatory ParameterBrazil (ANVISA - RDC 751/2022)Mexico (COFEPRIS)
Risk ClassificationClass I, II, III, IV (Aligned with EU MDR)Class I, II, III (Based on contact duration and invasiveness)
Low-Risk Consumables (Class I/II)Notificação (Simplified electronic dossier)Registro Sanitario (Simplified low-risk pathway)
High-Risk Consumables (Class III/IV)Registro (Full technical dossier review)Registro Sanitario (Full dossier or Equivalence Pathway)
Quality System AuditMDSAP or ANVISA CBPF (Good Manufacturing Practice)ISO 13485:2016 certificate accepted
Local Entity RequirementBRH (Brazil Registration Holder) licensed companyMexico Registration Holder (MRH) holding sanitary license
Language RequirementPortuguese technical summaries and labelingSpanish technical summaries, IFUs, and packaging
Registration ValidityClass I/II: Indefinite / Class III/IV: 10 Years5 Years (Renewable)
Manshav Impex Latin America ANVISA and COFEPRIS compliance, Portuguese/Spanish packaging, and Santos/Manzanillo logistics.
ANVISA RDC 751/2022 technical documentation milestones, COFEPRIS equivalence pathways, and Atlantic/Pacific ocean transit.

Brazil ANVISA RDC 751/2022 Technical Dossier Architecture

Enacted in March 2023 and fully enforced, RDC 751/2022 modernized Brazil's device framework. All technical dossiers must follow the IMDRF Table of Contents format:

  • Chapter 1 - Device Description: Raw material composition (e.g. medical-grade virgin polypropylene, 300-series surgical steel, natural rubber latex compounding).
  • Chapter 2 - Risk Management File: Conforming strictly to ISO 14971:2019, documenting all clinical hazard mitigations.
  • Chapter 3 - Pre-Clinical Validation: Biocompatibility per ISO 10993 (Cytotoxicity, Irritation, Sensitization, Systemic Toxicity, and Pyrogenicity).
  • Chapter 4 - Sterilization & Packaging: Validation reports under ISO 11135 (EtO) or ISO 11137 (Gamma) proving a Sterility Assurance Level of 10^-6, accompanied by accelerated shelf-life stability data.

Maritime Shipping to Port of Santos & Manzanillo

Destination PortTarget MarketOcean Transit TimeContainer Frequency
Port of Santos (BRSSZ)Brazil (São Paulo, Rio de Janeiro)28 – 35 Sailing DaysWeekly departures via Atlantic line
Port of Manzanillo (MXZLO)Mexico (Pacific Coast, Guadalajara, CDMX)24 – 30 Sailing DaysBi-weekly departures via Pacific route
Port of Callao (PECLL)Peru (Lima medical corridor)30 – 36 Sailing DaysMonthly consolidation service
Port of San Antonio (CLSAI)Chile (Santiago CENABAST tenders)32 – 38 Sailing DaysMonthly consolidation service
Request ANVISA-compliant technical dossiers in Portuguese/Spanish, product samples, and CIF Santos/Manzanillo quotations.
Request LatAm Dossier & Quote
🏭 Export Sourcing DeskIndian Manufacturer & Exporter — Vetted Factory Network
Hypodermic Disposable Syringes (2-Part & 3-Part, 2ml to 50ml) manufacturer India

Hypodermic Disposable Syringes (2-Part & 3-Part, 2ml to 50ml)

High-precision sterile single-use disposable syringes with Luer-Lock and Luer-Slip options, clear graduation barrel, smooth gliding medical-grade plunger, and mounted ultra-sharp hypodermic needles. Container consignments dispatched from Port Mundra & Port Nhava Sheva, with certificates and test reports shared with every quotation.

Made to CE MDRMade to ISO 13485Made to ISO 7886-1MOQ: 100,000 pcs

Frequently asked questions

What is the impact of ANVISA RDC 751/2022 on medical consumable imports to Brazil?

RDC 751/2022 aligned Brazil's classification with the EU MDR, introducing stricter risk classification rules, mandatory UDI labeling, and formalized IMDRF technical dossier structures, while simplifying Class I and II notifications.

Can Mexican distributors use the COFEPRIS Equivalence Pathway with Indian manufacturers?

Yes. If the manufacturer holds recognized reference country approvals (such as US FDA 510(k), Health Canada, or Japan PMDA), COFEPRIS provides a fast-track review that shortens sanitary registration timelines from 12-18 months to under 4-6 months.

Does Manshav Impex provide technical documentation in Spanish and Portuguese?

Yes. We supply comprehensive technical summaries, IFUs, packaging artwork, and Certificates of Analysis translated and notarized in Spanish and Brazilian Portuguese.

What is the typical ocean sailing time from India to the Port of Santos in Brazil?

Ocean freight transit from Mundra or Nhava Sheva to the Port of Santos (São Paulo) typically takes 28 to 35 days via Atlantic maritime routes.

Do you support private labeling for Latin American hospital distributor brands?

Yes. We offer complete OEM contract manufacturing with custom-branded inner boxes and outer master cartons featuring your local registration numbers and barcoded Portuguese/Spanish labeling.

Sharmil Mangukiya (Founder & MD)

Sharmil Mangukiya is the founder and managing director of Manshav Impex, an Indian manufacturer & exporter of medical disposables serving importers, distributors, hospitals and governments in 48+ countries since 2019.

Chat with us